Edit |   |
---|---|
Antigenic Specificity | CD195, Human (Leronlimab biosimilar) |
Clone | Leronlimab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD195 Recombinant Antibody. Leronlimab (codenamed PRO 140) is a humanized monoclonal antibody targeted against the CCR5 receptor found on T lymphocytes of the human immune system. It is being investigated as a potential therapy in the treatment of COVID-19, triple negative breast cancer, and HIV infection. |
Immunogen | n/a |
Other Names | Anti-CD195 Recombinant Antibody, Research Grade Leronlimab, Anti-Human CD195 Recombinant Antibody, HuPRO-140, PA-14, PRO-140, Antibody Drug Analogues, Monoclonal Antibody, YR1503, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 674782-26-4 |
Catalog # | YR1503 |
Price | please inquire |
Order / More Info | CD195, Human (Leronlimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |